8.26

1.85% 0.15

After Hours: 8.14 -0.12 -1.45%

Mind Medicine Inc (MNMD)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Mind Medicine Inc stock is traded at $8.26, with a volume of 1.08M. It is up +1.85% in the last 24 hours and up +36.53% over the past month. Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.

Previous Close:

$8.11

Open:

$8.16

24h Volume:

1.08M

Relative Volume:

1.00

Market Cap:

$595.82M

Revenue:

$11.40B

Net Income/Loss:

$-95.73M

P/E Ratio:

-4.1508

EPS:

-1.99

Net Cash Flow:

$-64.37M

1W Performance:

+9.84%

1M Performance:

+36.53%

6M Performance:

+0.36%

1Y Performance:

+172.61%

1-Day Range:

$7.94

$8.39

1-Week Range:

$6.99

$8.54

52-Week Range:

$2.91

$12.22

Mind Medicine Inc Stock (MNMD) Company Profile

Name

Mind Medicine Inc

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

212-220-6633

Address

ONE WORLD TRADE CENTER, NEW YORK

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

MNMD's Discussions on Twitter

Compare MNMD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MNMD Mind Medicine Inc	8.26	595.82M	11.40B	-95.73M	-64.37M	-1.99
VRTX Vertex Pharmaceuticals Inc	464.56	119.70B	10.63B	-479.80M	-1.35B	13.33
REGN Regeneron Pharmaceuticals Inc	754.87	82.75B	13.85B	4.65B	3.32B	35.06
ARGX Argen X Se Adr	614.59	36.73B	1.86B	-40.29M	-1.28B	-4.16
ALNY Alnylam Pharmaceuticals Inc	253.74	32.53B	2.09B	-332.26M	16.06M	-4.14
BNTX Biontech Se Adr	120.72	28.50B	3.30B	-501.07M	1.03B	11.54

Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-14-24	Resumed	Leerink Partners	Outperform
Jul-24-24	Initiated	ROTH MKM	Buy
May-29-24	Initiated	Robert W. Baird	Outperform
Apr-15-24	Initiated	Leerink Partners	Outperform
Dec-05-23	Initiated	Canaccord Genuity	Buy
Dec-09-22	Resumed	ROTH Capital	Buy
Nov-16-22	Initiated	RBC Capital Mkts	Outperform
Aug-26-22	Initiated	Oppenheimer	Outperform
Aug-10-22	Initiated	Cantor Fitzgerald	Overweight
May-04-22	Initiated	ROTH Capital	Buy
Jun-28-21	Initiated	Maxim Group	Buy

View All

Mind Medicine Inc Stock (MNMD) Latest News

Nov 26, 2024

Mind Medicine (NEOE:MMED) Change In Inventory : C$0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 25, 2024

MindMed's SWOT analysis: psychedelic stock's potential in anxiety treatment - Investing.com

Nov 25, 2024

Nov 22, 2024

Roth Capital Issues Pessimistic Estimate for MNMD Earnings - MarketBeat

Nov 22, 2024

Mind Medicine Inc Issues Letter to Shareholders - Marketscreener.com

Nov 22, 2024

Nov 21, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $25.38 Average Price Target from Brokerages - MarketBeat

Nov 21, 2024

Nov 19, 2024

Generalized Anxiety Disorder Market to Reach New Heights - openPR

Nov 19, 2024

MindMed recruits regulatory expert ahead of Phase III trials - The Pharma Letter

Nov 19, 2024

Nov 18, 2024

MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer - BioSpace

Nov 18, 2024

MindMed Appoints Former Karuna Executive to Lead Phase 3 Regulatory Strategy | MNMD Stock News - StockTitan

Nov 18, 2024

Nov 17, 2024

(MNMD) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 17, 2024

Nov 16, 2024

Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Nov 16, 2024

Nov 15, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpHere's What Happened - MarketBeat

Nov 15, 2024

Stock Traders Purchase Large Volume of Call Options on Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat

Nov 15, 2024

COMMODORE CAPITAL LP Acquires Shares in Mind Medicine Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey

Nov 14, 2024

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions - Yahoo Finance

Nov 14, 2024

Nov 13, 2024

Mind Medicine Mindmed Inc (MNMD-Q) QuotePress Release - The Globe and Mail

Nov 13, 2024

Can Canada’s psychedelic drug developers shake off the sector’s bad trip? - The Globe and Mail

Nov 13, 2024

MindMed to Participate in Upcoming Investor Conferences - Business Wire

Nov 13, 2024

MindMed (MNMD) to Present at Major Healthcare Investor Conferences in London, Florida | MNMD Stock News - StockTitan

Nov 13, 2024

Nov 11, 2024

Mind Medicine (MindMed)'s (MNMD) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Nov 11, 2024

Nov 10, 2024